#### IV/PO model

Caffeine physiochemical properties and ADME parameters were incorporated from the model developed by Britz, Hanke (12). **Table 1** presents the drug specific parameters of caffeine and the values used in the healthy adult IV model.

The healthy PBPK model development was based on single dose IV and oral PK studies described in Britz, Hanke (12). These doses consisted of 3 mg/kg, 5 mg/kg, 250 mg, 500 mg.

**Table 1. Physicochemical properties and ADME of caffeine for the final IV/PO model**

| **Physicochemical properties**    |                                      |
|--|--|
| Octanol:water coefficient (logP)           | -0.07 Log Units |
| Fraction unbound in plasma (f<sub>u</sub>) | 0.7 |
| Molecular weight (MW)                      | 194.2 g/mol |
| pKa                                        | 0.8 |
| Water solubility                           | 21.6 mg/mL |
| **ADME**                                   |                             |
| Partition coefficient                      | PK-Sim Standard |
| Cell permeability                          | PK-Sim Standard |
| CYP1A2 concentration                       | 1.08 µM |
| CYP1A2 K<sub>M</sub>                       | 14.7 µM |
| CYP1A2 K<sub>cat</sub>                     | 1.01 1/min |
| CL<sub>ren</sub>                           | 2.46E-3 1/min |
| Specific intestinal permeability (transcellular) | 3.03E-5 cm/min |
| **Oral absorption parameters**             |                             |
| Formulation: Solution                      |                             |
